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ABSTRACT
Elongation factor P (EF-P) is a conserved ribosome-
binding protein that structurally mimics tRNA to
enable the synthesis of peptides containing motifs
that otherwise would induce translational stalling,
including polyproline. In many bacteria, EF-P
function requires post-translational modification
with (R)-b-lysine by the lysyl-tRNA synthetase
paralog PoxA. To investigate how recognition of
EF-P by PoxA evolved from tRNA recognition by
aminoacyl-tRNA synthetases, we compared the
roles of EF-P/PoxA polar contacts with analogous
interactions in a closely related tRNA/synthetase
complex. PoxA was found to recognize EF-P solely
via identity elements in the acceptor loop, the
domain of the protein that interacts with the
ribosome peptidyl transferase center and mimics
the 3’-acceptor stem of tRNA. Although the EF-P
acceptor loop residues required for PoxA recogni-
tion are highly conserved, their conservation
was found to be independent of the phylogenetic
distribution of PoxA. This suggests EF-P first
evolved tRNA mimicry to optimize interactions with
the ribosome, with PoxA-catalyzed aminoacylation
evolving later as a secondary mechanism to further
improve ribosome binding and translation control.
INTRODUCTION
Mimicry is the process by which one species or molecule
evolves to be similar to another (1,2). At the molecular level
(i.e. molecular mimicry), this is observed in several patho-
gens that have evolved molecular structures to resemble the
host’s own structures to evade or trigger a response from it
(2). An example of this is translation initiation factor 2A
(eIF2A) that is mimicked by K3L from poxviruses. During
viral infections, double-stranded RNA-dependent protein
kinase (PKR) phosphorylates eIF2A preventing protein
translation, which in turn decreases viral production. This
cellular defense mechanism placed a selective pressure on
the poxvirus, leading to the evolution of K3L (the mimic),
an inhibitor that binds the active site of PKR, thereby pre-
venting eIF2A phosphorylation (3).
In addition to the mimicry of molecules between inter-
acting species, the term ‘molecular mimicry’ is also used to
describe the convergent evolution of molecules that
coexist within the same species. Some of the most
intriguing examples of molecular mimicry are within the
transcription and translation apparatus where several
proteins mimic nucleic acids to control these processes
(4–6). For instance, several translation factors mimic
tRNA, which presumably allows these proteins to fit
properly within binding sites on the ribosome (6,7).
Perhaps one of the most striking examples is EF-P,
which not only resembles a complete tRNA molecule in
structure (Figure 1), but also emulates the tRNA before its
interaction with the ribosome.
EF-P is a non-essential elongation factor that has been
shown to facilitate the translation of several proteins
involved in pathogenesis and survival under other stressful
conditions (8,9). Many EF-P-regulated proteins have a
stretch of prolines or other sequence patterns that
induce ribosome stalling during translation. EF-P is
required for alleviating the stalling of these paused ribo-
somes, allowing for the translation of these genes to
continue (10–12). To function efficiently in translation,
EF-P is (R)-b-lysylated at Lys34 (Escherichia coli number-
ing), a position structurally equivalent to A76 in tRNA
(10,13,14). The modification of EF-P is catalyzed by
PoxA, a protein paralog of the catalytic domain of
lysyl–tRNA synthetase (LysRS). All aminoacyl–tRNA
synthetases (aaRS) including LysRS catalyze tRNA
aminoacylation in a two-step reaction. First, the substrate
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amino acid is activated with ATP forming an aminoacyl
adenylate (aa-AMP) that usually remains stably bound to
the enzyme in the absence of tRNA. In a second step, the
amino acid is transferred from AMP to the 3’ or 2’ OH of
A76 at the 3’-end of tRNA:
aa+ATP$ PPi+aa-AMP
aa-AMP+tRNA$ aa-tRNA+AMP
Similar to all known aaRSs, PoxA also catalyzes the
aminoacylation of EF-P in a two-step reaction, which in
this case requires ATP and (R)-b-lysine ((R)-b-Lys), an
analog of a-lysine that has the amino group in the beta
instead of the alpha position (8,14):
Rð Þ--Lys+ATP$ PPi+Rð Þ--lysyl-AMP
ðRÞ--lysyl-AMP+EF-P$
ðRÞ--lysyl-EF-P+AMP
(R)-b-Lys is transferred to Lys34 of EF-P forming an
(R)-b-lysyl-lysine amino acid. This group is further
hydroxylated to form (R)-b-lysyl-hydroxylysine in a
reaction catalyzed by the product of the yfcM gene (15).
Until now it has not been possible to find the physiological
relevance of this hydroxylation, as it is not required for
alleviating stalled ribosomes, and yfcM deletion strains do
not present any obvious phenotype (10,16).
While PoxA modifies EF-P in a reaction that resembles
those catalyzed by aaRSs, the extent of EF-P mimicry to
tRNA is unknown. Therefore, we set out to investigate
whether EF-P mimics tRNA, not only in structure, but also
in its interaction with the LysRS paralog, PoxA. Our results
show that PoxA recognizes EF-Pmainly through interactions
at positions mimicking the acceptor stem of tRNA. Thus,
PoxA has retained and even strengthened interactions that
were already relevant for recognition of tRNA by aaRSs.
Most of the conserved positions in the EF-P sequence corres-
pond to residues contacting the ribosome, with PoxA only
recognizing a small subset of these conserved positions. This
suggests EF-P first evolved tRNA mimicry to interact with
the ribosome, whereas PoxA evolved afterward in a subset of
bacterial species to recognize EF-P. The absence of PoxA in
many bacteria and the presence of a different pathway for the
modification of the EF-P paralog in archaea and eukaryotes
(IF5a) further support the hypothesis that tRNA mimicry in
this pathway originated to allow for interaction between
EF-P and the ribosome, whereas PoxA recognition of the
mimic is a more recent addition.
MATERIALS AND METHODS
Strains and vectors, cloning and mutagenesis
EF-P and PoxA were expressed in BL21 XJB (DE3)
strains from plasmids EFP pTYB11 and PoxA
Figure 1. Contact surface in EF-P/PoxA and tRNAAsp/AspRS complexes. The image shows a comparison of the polar contacts between EF-P and
PoxA with polar contacts between tRNAAsp and AspRS. Image corresponds to a superposition of AspRS and PoxA from pdb files 1asy (chains A
and R) and 3a5z (chains C and D). AspRS is in blue, tRNAAsp in orange, PoxA in magenta and EFP in green. Amino acids and nucleotides making
polar contacts are marked in balls with the following colors: AspRS in light blue, tRNAAsp in light orange, EFP in light green and PoxA in red.
(A) Enzymes. (B) Substrates.
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pTYB11 (14). To add a phosphorylation site for the cata-
lytic subunit of the cAMP-dependent protein kinase A
(PKA) at the carboxy terminus of EFP in the pTYB11
plasmid, efp was amplified by polymerase chain reaction
using the primers: EFP-fd (GCAACGTACTATAGCAA
CGAT) and EFP-PKA-XmaI-Rv (GTCACCCGGGCTC
CGATTAAACAGATGCACGACGCTTCACGCGAG
AGACG). The amplified DNA was digested and inserted
into the EFP pTYB11 plasmid at XmaI restriction site and
the efp internal EcoRI site. efp and poxA mutations were
performed by polymerase chain reaction amplification and
DpnI digestion using the primers listed in Supplementary
Table S1 (PoxA) and Supplementary Table S2 (EFP)
together with PoxA pTYB11 or pWN403 [pBAD18-
poxA; (8)] and EFP pTYB11 as templates, respectively.
All cloning and mutagenesis were confirmed through
sequencing at the Plant Microbe Genomics Facility at
The Ohio State University and then transformed in
E. coli BL21 XJB (DE3) cells for overexpression and
purification.
Sensitivity assays
Complementation assays were performed in Salmonella
typhimurium 14028s using plasmid pWN403 (pBAD18-
poxA) and mutation variants as previously described
(8,9). Briefly, hypo-osmolarity was assessed by streaking
Salmonella on antibiotic medium 2 agar (AB2; Difco,
Detroit, MI, USA). Plates were incubated at 37C for
16 h followed by visual assessment of colony size. For
gentamicin and lauryl sulfobetaine sensitivity, overnight
cultures of Salmonella strains were diluted 1:1000 into
fresh Luria-Bertani medium containing either gentamicin
(3.125 mg/ml) or lauryl sulfobetaine (6.25mM). Growth
was assessed by turbidity following 16 h of incubation at
37C with shaking. In this condition, all strains grow up to
1–1.15 OD600 units in the absence of gentamicin and
sulfobetaine.
Purification of PoxA, EF-P and variant proteins
All proteins were expressed using autoinduction media
and then purified as previously reported (14). Briefly,
cells were resuspended in buffer A (50mM Tris HCl, pH
8.0, 500mM NaCl and 10% glycerol) plus 0.05% triton
X-100 and lysed by sonication. Cell debris was eliminated
by centrifugation and the supernatant loaded to a chitin
column. Column was washed with five volumes of buffer
A plus 0.05% triton X-100, and then with 25 volumes of
buffer A. Finally, the column was washed with 2 volumes
of buffer A plus 100mM dithiothreitol and incubated
overnight at 4C. After this, the protein was eluted with
buffer A and concentrated using a filter centrifugation
unit with a MWCO of 3 KDa. Then the protein was
dialyzed against dialysis buffer (25mM Tris HCl, pH
8.0, 150mM NaCl and 4mM 2-mercaptoethanol) plus
50% glycerol and stored at 20C. EF-P used for kcat/
KM determinations was further purified through anion
exchange using a Resource Q column. Protein was
loaded on the column and washed with 10 volumes of
buffer 1 (25mM Tris HCl, pH 8, 50mM NaCl and
2mM 2-mercaptoethanol), then with additional 6
volumes of 10% buffer 2 (25mM Tris HCl, pH 8, 1M
NaCl and 2mM 2-mercaptoethanol) in buffer 1. Finally,
the protein was eluted in a linear gradient to 14% buffer 2
in buffer 1, concentrated and dialyzed against dialysis
buffer plus 20% glycerol. The protein was then stored in
aliquots at 80C. All proteins were quantified in 6M
guanidinium HCl based on absorbance at 280 nm and a
molar extinction coefficient of 24750M-1 cm-1 (EF-P) or
29870 M1 cm1 (PoxA) that were calculated using
EMBOSS (17).
Phosphorylation of EF-P-PKA
EF-P-PKA was phosphorylated for 1 h at 30C in a
reaction mixture that contained 60 mM EF-P-PKA,
50mM Tris HCl, pH 7.5, 10mM MgCl2, 1.4 mM
(9mCi/ml) 32P-gATP, 200 mM ATP and 30 U/ml PKA
(NEB). Then the 32P-EF-P-PKA was purified using a
DEAE sepharose column at room temperature. The
protein was loaded and the column was cleaned with 50
volumes of buffer 1, then with additional 15 volumes of
5% buffer 2 in buffer 1 and eluted with 10% buffer 2 in
buffer 1. The purified protein was dialyzed against dialysis
buffer with 50% glycerol and stored in aliquots at 80C.
Active site titration of PoxA
PoxA active site titration was made in a reaction mix con-
taining 0.1M glycine, pH 9.0, 30mM KCl, 10mM MgCl2,
30 mM ATP, 0.0065 mM (0.02 mCi/ml) 32P-aATP, 2.5mM
2-mercaptoethanol, 4.2 U/ml pyrophosphatase and 4mM
(R)-b-Lys. Reactions were started by adding enzyme and
performed at room temperature. At specific time points,
aliquots were taken and quenched by mixing with 2.5
volumes of 0.2M Na acetate, pH 5.0. Aliquots (0.5 ml) of
each sample were separated on PEI-F cellulose plates using
0.1M ammonium acetate plus 5% acetic acid as mobile
phase. Plates were analyzed using phosphorimaging, and
PoxA active sites were quantified from the plateau of the
(R)-b-lysyl-AMP intermediate formation.
Aminoacylation of EF-P with 14C-a-lysine
EF-P aminoacylation with 14C-a-Lysine was performed
at 37C in a mixture containing 100mM glycine, pH 9.0,
30mM KCl, 10mM MgCl2, 8mM ATP, 3mM
2-mercaptoethanol, 8.4 U/ml pyrophosphotase and
0.75mM EFP. At defined time points, 6 ml of reaction
mixture was precipitated on 5% trichloroacetic acid
saturated 3MM Whatman paper. The papers were
washed three times with 5% trichloroacetic acid, once
with ethanol and dried at 85C. Then the 14C
aminoacylated EF-P was quantified using scintillation
counting. Additionally, aliquots of the reaction were
separated in a sodium dodecyl sulphate-polyacrylamide
gel electrophoresis, and 14C a-Lysyl-EF-P was detected
by phosphorimaging to confirm aminoacylation of EF-P.
Aminoacylation of EF-P with (R)-b-Lys
Aminoacylation kinetics of EF-P with (R)-b-Lys were
assayed at 37C in a mixture containing 100mM glycine,
pH 9.0, 30mM KCl, 10mM MgCl2, 2.5mM
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2-mercaptoethanol, 0.1mg/ml bovine serum albumin,
saturating concentrations of ATP (2–8mM depending
on the PoxA mutant), 6–8mM (R)-b-Lys, 4 nM 32P-EF-
P-PKA as a probe for EF-P aminoacylation and variable
concentrations of EF-P (0.5–2.5 mM). Reaction aliquots
were taken at defined time points and quenched in an
equal volume of stop solution (2% triton X-100, 1%
2-mercaptoethanol, 750mM Na acetate, pH5.0).
Aminoacylated and non-aminoacylated forms of 32P-EF-
P-PKA were separated through isoelectric focusing
using a 4.5–5.4 pH gradient (Pharmalyte 4.5–5.4
GE-Healthcare) and subsequently quantified using
phosphorimaging.
Sequence and structure analysis
Structure interfaces and polar contacts were determined
using PDBe PISA (18). Additional polar contacts previ-
ously described were also included (13). Figures were
made with The PyMOL Molecular Graphics System
(version 1.2.0.3 Schrödinger, LLC). Alignments of 112 se-
quences of EF-P from organisms of diverse genera were
performed with PROMALS3D (19) using EF-P structures
from pdb 3a5z-D, 1ueb-A, 3oyy-A to guide the alignment.
WebLogo representation of this alignment, as well as from
a subset of the sequences with or without a Lys residue in
the modification position (Supplementary Tables S3 and
S4), was performed using the WebLogo online server (20).
Variability of each position on the sequence alignments
was calculated using the Shannon entropy analysis of
the protein variability server (21).
RESULTS
Equivalent contacts between PoxA/EF-P and
aspartyl-tRNA synthetase/tRNA are within the
acceptor stem
To investigate how PoxA evolved from LysRS to acquire
its substrate specificity for a protein rather than RNA, it
would be ideal to first compare the structure of EF-P
bound to PoxA with that of tRNALys bound to LysRS.
tRNALys is not well resolved in the corresponding crystal
structure (22), so instead we compared the EF-P/PoxA
complex structure with that of tRNAAsp bound to
aspartyl-tRNA synthetase (AspRS) (pdb 1asy). AspRS is
closely related to LysRS in structure and, together with
AsnRS, they form the class IIb group of aaRSs (23,24),
which share common tRNA identity elements, including
the discriminator base (25–27). In addition, the effects of
several alanine substitution mutations on the contact
surface of the tRNAAsp/AspRS complex have been
studied (27), providing a useful reference for comparisons
with EF-P/PoxA complex.
AspRS, in common with all class IIb aaRSs, has two do-
mains: a catalytic domain that interacts with the acceptor
stem of tRNA and an anticodon-binding domain that
binds to the anticodon stem loop (Figure 1). Most of the
binding energy comes from interactions with the anti-
codon-binding domain (27) that is absent from PoxA,
which contains only the catalytic domain. Focusing on
the polar contacts (Figure 1 and Table 1), we observe
within the catalytic domain of both enzymes some inter-
actions that have been lost from the EF-P/PoxA complex,
others that are conserved (Glu102, Glu103, Arg106 and
His108 from PoxA) and a group representing novel inter-
actions not present in the AspRS complex (His52, Asp177,
Asn180, Glu185, Gln193, Ser218, Arg235, Glu244 and
Arg303 from PoxA). Most of the common contacts cor-
respond to AspRS interactions with nucleotides 73 (dis-
criminator base) and 74 of tRNAAsp. The equivalent
positions are located in domain 1 (N-terminal) of EF-P
along with all of the novel contacts. Non-polar and polar
interactions between EF-P and PoxA have similar distri-
butions, with the only notable differences being in a group
of contacts formed between EF-P and the second
monomer in the PoxA dimer (Pro63, Gly64, His65,
Ser66 and Gln67 from PoxA) (Supplementary Figure
S1). Overall, this distribution indicates that most of the
EF-P surface does not contact PoxA and, furthermore, the
protein is tilted 60 compared with tRNAAsp binding to
AspRS, with domain III of EF-P displaced from where the
anticodon binding domain would have been in a class IIb
aaRS (Supplementary Figures S1 and S2) (13). To deter-
mine the roles of the retained and novel interactions, we
constructed alanine replacement variants for all
PoxA residues involved in polar interactions with
EF-P and further analyzed their effect on EF-P
aminoacylation.
Table 1. Polar contacts between EF-P and PoxAa
PoxA EFP
Amino acid Position Atom Amino acid Position Atom
His 52 O Lys 31 NZ
His 52 O Lys 31 CE
His 52 ND1 Lys 34 O
His 52 ND1 Gly 35 O
His 52 ND1 Gln 36 N
Glu 102 O Lys 31 NZ by
H2O-mediated
hydrogen bond
Glu 103 OE1 Lys 31 NZ
Glu 103 OE2 Lys 31 NZ
Arg 106 NH1 Glu 28 OE1
Arg 106 NE Glu 28 OE2
Arg 106 NH1 Glu 28 OE2
His 108 NE2 Lys 31 O
Asp 177 OD1 Lys 54 NZ
Asp 177 OD2 Lys 54 NZ
Asn 180 ND2 Thr 55 O
Glu 185 OE1 Lys 57 NZ
Gln 193 NE2 Gly 33 O
Gln 193 NE2 Lys 34 O
Ser 218 O Lys 34 NZ
Arg 235 NH2 Gly 33 O
Glu 244 OE1 Gly 33 N
Glu 244 OE2 Gly 33 N
Arg 303 NH1 Lys 31 O by
H2O-mediated
hydrogen bond
Arg 303 NH2 Lys 31 O by
H2O-mediated
hydrogen bond
aContacts determined using PDBE Pisa. Additional contacts previously
reported are also included (13).
3264 Nucleic Acids Research, 2014, Vol. 42, No. 5
In vitro characterization of PoxA catalyzed amino acid
activation and aminoacylation
The catalytic activities of aaRSs are commonly monitored
using radiolabeled amino acids. As radioactive (R)-b-Lys
is not commercially available, we developed alternative
strategies to characterize PoxA activity in vitro. Active
site titration was performed using a-32P-ATP and non-
radioactive (R)-b-Lys, which allowed monitoring of ATP
degradation as well as the formation of 32P-AMP and
32P-(R)-b-lysyl adenylate by TLC and phosphorimaging
quantification. Some aaRS show half-of-the-sites reactiv-
ity, meaning that only one of the monomers in the dimer
at a time can perform amino acid activation (28). To de-
termine whether this is true for PoxA, we calculated the
concentration of functional PoxA active sites, which were
considered to be equivalent to the concentration of
32P-(R)-b-lysyl adenylate at the plateau of the reaction, a
method commonly used with aaRSs. Doubling the enzyme
concentration resulted in a 2-fold increase of the plateau
level, confirming that the substrate concentration was
saturating for the reaction. Enzyme concentrations
calculated for purified WT PoxA were usually within
90–95% of concentrations calculated from spectrophoto-
metric determinations (data not shown). The fact that
active site titration of PoxA correlated reasonably well
with spectrophotometric quantifications suggests that
both PoxA monomers are active in the dimer at the
same time. During active site titration, the concentration
of 32P-(R)-b-lysyl adenylate plateaued after the first time
point (15 s) for WT and most of the PoxA variants. Some
PoxA variants were slower than WT (R106A, R235A and
especially R303A), whereas others were almost completely
inactive (E244A; Table 2). Owing to the low activity
observed during (R)-b-lysyl adenylate formation, PoxA
E244A was not analyzed further.
PoxA recognizes EF-P through residues that mimic the
tRNA 3’-end
To compare the role of the contacts that are specific to the
EF-P/PoxA complex with those that are common to other
class IIb aaRSs, we measured the effect of the correspond-
ing alanine substituted variants on PoxA’s ability to
aminoacylate EF-P with (R)-b-Lys. Modification of EF-
P with (R)-b-Lys adds a positive charge that allows for the
separation of the modified protein from the non-
aminoacylated form by isoelectric focusing. To allow
quantification of both modified and unmodified EF-P,
we added a phosphorylation site at the carboxy terminus
of EF-P far from the interaction surface with PoxA.
Phosphorylation of this site using the catalytic subunit
of the cAMP-dependent protein kinase (PKA) and g-32P
ATP allowed us to quantify the fraction of lysylated EF-P
by analyzing phosphor images of the samples separated by
isoelectric focusing (Supplementary Figure S3). Based on
their aminoacylation activity, the PoxA variants can be
divided in three main groups (Table 2). The majority of
amino acid replacements have little or no effect on PoxA
activity. These include PoxA E102A, R106A, N180A,
Q193A, S218A and R303A, which have a kcat/KM of at
least 70% of the WT protein. A second group composed
of H52A, D177A and E185A showed a moderate loss of
activity, with a kcat/KM between 20 and 50% of WT PoxA.
The third group composed of E103A, H108A and R235A
retains no detectable activity for aminoacylation of EF-P
with (R)-b-Lys.
All inactivating replacements map to PoxA residues
that interact with a loop region of EF-P domain 1 where
Lys34, the modification site, is located (Figure 2). One of
these residues is Glu103 that hydrogen bonds to Lys31 of
EF-P (2.9 Å). The equivalent interaction in the tRNAAsp/
AspRS complex corresponds to Ser329 (Glu264 in E. coli
LysRS) that is at hydrogen bonding distance from the
discriminator base (G73) (2.5 Å) and is also in close
contact with C74 (3.7 Å) of tRNAAsp. Replacement of
Ser329 as well as any of the two other amino acids of
AspRS that contact the discriminator base (Asn328 and
Thr331) had only a mild effect on efficiency of tRNAAsp
aminoacylation (27). Replacement of the PoxA residues
that correspond to Asn328 and Thr331 (Glu102 and
Arg106) did not affect EF-P aminoacylation. In
contrast, replacement of Glu103 in PoxA completely
inactivated the enzyme, indicating a much more important
role for this position than observed in the corresponding
aaRSs.
His108 of PoxA also forms a hydrogen bond with Lys31
through interactions to the backbone oxygen (3.3 Å), and
additionally is in close contact with Phe29 (3.4 Å). PoxA
His108 corresponds to one of the most conserved residues
in structural motif 2 of AspRS, His334 (His270 in E. coli
LysRS), which contacts C74 of tRNAAsp. As with His108
of PoxA, replacement of His334 in AspRS severely
reduced substrate binding affinity and aminoacylation
(27). In AspRS, substitution of this His with Ala also
reduced the rate of amino acid activation (27). In
contrast, replacement of His108 in PoxA did not
produce any significant effect on the amino acid activation
reaction (Table 2), indicating that the role of this His
residue has partially diverged between the two enzymes.
The third replacement that inactivates PoxA corres-
ponds to R235A. Arg235 contacts the backbone oxygen
of Gly33 (3.6 Å) and Lys34 (4.0 Å) of EF-P. This arginine
corresponds to Ser469 of AspRS, which does not contact
tRNAAsp. E. coli LysRS has an arginine (Arg412), which
structurally co-localizes with Arg235 of PoxA. Although
tRNALys is not well resolved in the LysRS crystal struc-
ture, superposing LysRS to AspRS reveals that one of the
A76 phosphate oxygens from tRNAAsp is a short distance
from Arg412 of LysRS (5.2 Å), suggesting a possible direct
contact with tRNA. Independently of this, we consider
Lys34 of EF-P to be functionally analogous to A76 of
tRNA, as both are sites of aminoacylation.
Alternatively, Lys34 may be viewed as a structural
mimic of C75 of tRNAAsp, as both co-localize in the struc-
tural alignment between AspRS and PoxA (Figure 2B).
Structural alignment of the EF-P/PoxA complex with
tRNAAsp/AspRS shows that Phe29 of EF-P localizes in
a position similar to G73 in tRNAAsp and Lys31 is near
C74. These different EF-P residues are grouped together
in what we refer to as the acceptor loop, which structurally
and functionally mimics the 3’-end of the acceptor stem of
tRNA (Figure 2A and B).
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Replacement of most amino acids involved in the polar
contacts that are unique to the PoxA/EF-P complex
(i.e. absent from the tRNAAsp/AspRS complex) have a
minimal effect on aminoacylation activity. The only ex-
ceptions were R235A (discussed earlier) along with three
other variants with modest effects on activity, H52A,
D177A and E185A (Figure 2C). His52 contacts the
acceptor loop of EF-P (with contacts to Lys31, Lys34,
Gly35 and Gln36), but the other two amino acids from
this group interact with amino acids outside the acceptor
loop in a region that is not used by AspRS to contact
tRNAAsp.
EF-P identity elements
Replacement of most of the amino acids in PoxA involved
in polar contacts with EF-P did not lead to any significant
effect on the aminoacylation kinetics, with the exception of
three positions that contact Phe29, Lys31, Gly33 and Lys34
in the acceptor loop. To confirm the relevance of these
contacts, we replaced each of these amino acids with Ala
in the EF-P acceptor loop and analyzed their effect on
aminoacylation with 14C-a-lysine (Figure 3). Previous ex-
periments have shown that substituting Lys34 with either
Arg or Ala prevents aminoacylation of EF-P (13,14).
Replacements of Phe29 and Lys31 with Ala also completely
abolished PoxA aminoacylation, confirming their role as
identity elements (Figure 3). Substitution of Gly33 with
Ala also greatly diminished PoxA’s ability to modify EF-
P, although some aminoacylation activity was retained.
Taken together, our data indicate that residues Phe29,
Lys31, Gly33 and Lys34 are the identity elements of EF-
P for PoxA aminoacylation and that these amino acids are
clustered in the acceptor loop. These contacts mimic those
of the tRNA acceptor stem with the aaRS, while novel
contacts elsewhere have at most a secondary role in this
interaction. Although EF-P and tRNAs are composed of
different monomers and bind their respective enzymes with
different geometries (Supplementary Figure S2), our data
indicate that the EF-P/PoxA complex evolved a molecular
recognition strategy that is analogous to the one used by
class IIb aaRSs, the evolutionary ancestors of PoxA.
Conservation of EF-P binding sites to PoxA and
the ribosome
It is well established that positions in a protein that
interact with other molecules tend to be more conserved,
as their variability during evolution is constrained by the
need to recognize their molecular partners, which imposes
a strong selective pressure (21,30). Thus, one would expect
in organisms where PoxA is present that the contacts
made to EF-P would be well conserved, especially in the
case of the four identity elements that are essential for
EF-P aminoacylation. Similarly, it would be predicted
that this would not be the case for EF-P from organisms
that lack the poxA gene, as these positions are not under
the same selective constrains. The acceptor loop and other
PoxA contacting positions are well conserved in EF-P se-
quences from organisms that encode a poxA gene (Table 3
and Figures 4 and 5 and Supplementary Figures S4 and
S5). The most conserved residues include the modification
site (Lys34 following E. coli EF-P numbering) and some
surrounding positions that are completely invariant (32,
33 and 35). Most contacts outside of the acceptor loop are
also well conserved, with some minor differences observed
for organisms that lack the poxA gene but retain a Lys at
position 34. Position 29, one of the four EF-P identity
elements, is usually Phe or Tyr in organisms that have
the poxA gene, but it is frequently His in organisms that
lack poxA. Other positions interacting with PoxA such as
residues 28 and 36 of the acceptor loop or 57 and 58 distal
from it show a similar pattern of conservation. Overall,
most positions in EF-P contacting PoxA are strictly
conserved, regardless of whether or not the corresponding
organism has a poxA gene. This includes all the other
identity elements (EF-P residues 31, 33 and 34), as well
as several other contacting positions (e.g. residues 8, 30,
Table 2. Effect of alanine substitutions on PoxA activity
PoxA variant
(AspRS equivalent)
Area of tRNA contacted
in AspRSa
Effect on amino
acid activation
kcat/KM (mM
1 s1)b Relative kcat/KM (R
c) DDGb
d(kcal/mol)
Wild type 0.05±0.005 1 –
H52A (gap) Gap Active 0.018±0.007 0.37 0.62
E102A (N328) Acceptor arm (G73) Active 0.049±0.022 0.98 0.011
E103A (S329) Acceptor arm (G73 +C74) Active Inactive – –
R106A (T331) Acceptor arm (G73) Reduced 0.055±0.005 1.1 0.057
H108A (H334) Acceptor arm (C74) Active Inactive – –
D177A (gap) Gap Active 0.027±0.003 0.53 0.39
N180A (gap) Gap Active 0.037±0.008 0.73 0.19
E185A (gap) Gap Active 0.013±0.002 0.27 0.81
Q193A (D421) No contact Active 0.055±0.009 1.1 0.057
S218A (E451) No contact Active 0.047±0.009 0.93 0.044
R235A (S469) No contact Reduced Inactive – –
E244A (E478) No contact Inactive Inactive – –
R303A (R531) No contact Reduced 0.044±0.004 0.87 0.086
aData from Eriani and Gangloff.27
bkcat/KM was estimated using sub-saturating EF-P concentrations from the slope of the equation, V= kcat [E][S]/KM.
cCompared with wild-type.
dGb represents differences in the transition state binding G and was estimated to be RTln[(kcat/KM)mut/(kcat/KM)WT] (29).
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32, 38, 40 and 55). The strong conservation of these
residues in EF-P, regardless of the presence of the poxA
gene, suggests that there are other constrains on their vari-
ability beyond the need to bind PoxA. The most likely
selective pressure that constrains variability of EF-P’s
surface amino acids is the need to maintain functional
interactions with the ribosome to prevent translational
stalling. Most of the EF-P residues that contact PoxA,
including all of the identity elements, also correspond
to positions that interact with the ribosome or tRNA
(Figures 4 and 5, Supplementary Figures S4 and S5), con-
sistent with their high degree of conservation even in the
absence of PoxA.
The ability of EF-P to functionally interact with both
PoxA and the ribosome poses questions as to the origins
of tRNA mimicry in this system. Amino acids contacting
PoxA are concentrated in domain 1, and the results
described above indicate that EF-P mimics only the tip
of the tRNA acceptor stem in its interaction with PoxA.
Conversely, amino acids contacting the ribosome are
distributed throughout the three domains of EF-P
(Figure 5 and Supplementary Figures S4 and S5), suggest-
ing that the overall similarity to the tRNA structure was
selected for optimal interaction with the ribosome. This
hypothesis is supported by the fact that PoxA deletions
have less severe phenotypes than EF-P deletions,
indicating that unmodified EF-P retains some activity on
the ribosome. For example, while both are clearly defect-
ive compared with WT, efp Salmonella strains grow
more slowly and display a lower gentamicin MIC than
isogenic poxA strains (9). Similarly, PoxA E103A and
R235A that inactivate PoxA aminoacylation activity are
unable to complement poxA strains, while transform-
ation with a plasmid coding for PoxA D177A (that
retains 50% of PoxA activity in vitro) complemented
all the tested WT phenotypes. PoxA H108A restored
only some of the phenotypes (growth on lauryl
sulfobetaine) (Figure 6), indicating that it retains some ac-
tivity, although we were unable to detect aminoacylation
in vitro. These observations also support the hypothesis
Figure 2. EF-P identity elements. (A) Active site of PoxA. PoxA
residues required for aminoacylation of EF-P and the corresponding
EF-P contact residues are highlighted. The a-lysyl-adenylate analog
50-O-[(L-lysylamino) sulfonyl] adenosine (KAA) is also represented.
(B) tRNA structural mimicry by EF-P identity elements. EF-P
identity elements and the relevant tRNA nucleotides are shown as
localized after superposition of PoxA and AspRS. (C) Active site of
PoxA. PoxA amino acids from the medium effect group and the EF-P
amino acids contacted by them are highlighted. Colors used in this
figure correspond to the color scheme of Figure 1.
Figure 3. Replacement of F29, K31 or G33 with alanine prevents EF-P
recognition by PoxA. WT and mutant EF-P were aminoacylated with
PoxA using 14C-a-lysine. (A) Plot shows aminoacylation of WT (circle),
F29A (square), K31A (rhombus) and G33A (triangle) EF-P with
14C-a-Lys. (B) After 6 h, aminoacylation samples were separated by
sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Top:
coomassie stained gel; bottom: phosphor image of the gel.
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Figure 4. Conservation of EF-P residues involved in PoxA contacts. WebLogo representation of a fragment of the alignment of diverse EF-Ps that
contain a lysine in the equivalent to the modification position. The top WebLogo (A) corresponds to an alignment of 14 EF-P sequences from
organisms that have a poxA gene encoded in their genome. The bottom WebLogo (B) corresponds to an alignment of 17 EF-P sequences from
organisms that do not have a poxA gene. The acceptor loop is marked with a black line, with the modification position highlighted with a triangle.
Contacts to PoxA (based on pdb 3a5z) are marked with red triangles and contacts to the ribosome (pdb 3huw and 3hux) are indicated with cyan
triangles. Numbering of the WebLogo positions corresponds to the full alignment, and corresponding positions on EF-P from E. coli are indicated
below the triangles (for full alignments see Supplementary Figure S4).
Table 3. Conservation of the amino acid sequence of the acceptor loop from EF-P
Positiona Organisms with PoxA Organisms without PoxA
Variabilityc Amino acid identityd Variabilityc Amino acid identityd
Glu28 1.198 Usually acid (71%) 1.993 Rarely acid (6%)
Phe29
b 1.611 Usually Phe or Tyr (79%) 0.952 Usually His (82%)
Val30 0.735 Usually Val (86%) 0.834 Usually Val (82%)
Lys31
b 1.292 Usually Lys (71%) 0.323 Usually Lys (94%)
Pro32 0.000 Pro (100%) 0.000 Pro (100%)
Gly33b 0.000 Gly (100%) 0.000 Gly (100%)
Lys34b 0.000 Lys (100%) 0.000 Lys (100%)
Gly35 0.000 Gly (100%) 0.000 Gly (100%)
Gln36 1.484 Usually Gln (71%) 2.190 Never Gln (0%)
Ala37 0.000 Ala (100%) 0.523 Usually Ala (88%)
Phe38 0.371 Usually Phe (93%) 1.277 Usually Phe or Tyr (88%)
Ala39 2.414 Variable 0.834 Usually Val (82%)
Arg40 0.735 Usually Arg (86%) 0.672 Usually Arg (82%)
aPositions are indicated according to E. coli EF-P numbering. Positions that contact PoxA are highlighted in bold letters.
bIdentity elements for PoxA aminoacylation.
cShanon entropy was calculated as an index of variability using Protein Variability Server. A value of 0 indicates no variability at all, whereas 4.322
indicates maximum variability (equal probability to find any of the 20 amino acids) (21).
dPercentage of occurrence of the amino acids in each position is in parentheses.
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that emergence of PoxA aminoacylation activity in bac-
terial evolution could have gradually improved fitness.
These results are in line with recent reports indicating
that unmodified EF-P can stimulate translation of
proteins with polyproline stretches, albeit with a much
lower efficiency than the modified protein (10), further
suggesting that EF-P may have originally functioned
without post-translational modification.
DISCUSSION
Our results demonstrate that EF-P is recognized mainly
through contacts with residues that mimic the 30-end of
the acceptor stem of tRNA. These amino acids are all
localized in a loop of domain 1 at the amino terminus of
EF-P that we have termed the acceptor loop, as it resem-
bles the acceptor stem of tRNA in both structure and
function. It is surprising that although EF-P closely resem-
bles almost the complete structure of a tRNA, PoxA
only relies on a small region of EF-P for its recognition
(Figure 5 and Supplementary Figure S4). This is in
contrast to the recognition of tRNA by a canonical
aaRS where the contacts are spread throughout the
entire tRNA (Figure 1) and identity elements are usually
located at both the acceptor and anticodon stems (31).
The only known exception is GluQRS, a paralog of the
Figure 6. Complementation of Salmonella DpoxA with poxA variants. Figure shows complementation assays for phenotypes associated with poxA
deletion mutants. Sensitivity to low osmolarity was assessed by the size of colonies grown on solid AB2 media (A), whereas sensitivity to gentamicin
(3.125 mg/ml) (B) and lauryl sulfobetaine (6.25mM) (C) was assessed as turbidity of cells grown on liquid media in presence of the corresponding
compound.
Figure 5. EF-P contacts with PoxA and the ribosome. Figure shows EF-P structures from pdb 3a5a-D (A and C) or 3huw-V (B and D). Atoms from
PoxA (C and E) or the ribosome and tRNA (D and F) that contact EF-P are highlighted in red. Variable positions of the alignments (Figure 4 and
Supplementary Figure S4) are highlighted on the EF-P surface for organisms with (C and D) or without (E and F) poxA. Variable positions are in
green and non-variable are in blue.
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catalytic domain of GluRS that aminoacylates the
queuosine-modified wobble base of tRNAAsp with glutam-
ate rather than the acceptor stem of tRNAGlu (32,33). In
this case, the tRNAAsp anticodon stem and loop mimic the
acceptor stem of tRNAGlu and are recognized by GluQRS
(34). Molecular docking experiments showed that
GluQRS does not contact most of the tRNAs (34) and
indicate that tRNAAsp nevertheless maintains a complete
canonical tRNA shape due to the evolutionary constrains
of its need to interact with AspRS, the translation machin-
ery and several nucleotide-modifying enzymes. In a similar
manner, the structure of EF-P is also constrained by the
need to maintain its interactions not only with PoxA, but
also with YfcM and the ribosome. Ribosome contacts are
well conserved and distributed throughout the structure of
EF-P (Figures 4 and 5 and Supplementary Figures S4 and
S5), in contrast to contacts with PoxA that are confined to
a subset of these residues (Figure 5 and Supplementary
Figures S4 and S5), supporting the idea that functionality
at the ribosome is the strongest determinant underlying
the structural and functional mimicry of tRNA by EF-P.
Furthermore, PoxA is mostly present in proteobacteria
and scarcely found in other bacteria (35), suggesting that
post-translation modification with (R)-b-Lys is a feature
that appeared only recently in evolution to improve the af-
finity of EF-P for the ribosome. Deletion of poxA gener-
ates phenotypes less severe than an efp deletion, indicating
that unmodified EF-P retains part of its activity on the
ribosome. Additionally, recent reports show that the role
of EF-P modification is mainly to enhance binding to the
ribosome and that unmodified EF-P can still stimulate
synthesis of proteins with polyproline stretches, although
with a much lower efficiency than its aminoacylated
version (10). The alternative hypothesis, where EF-P ori-
ginally interacted with PoxA and interaction with the
ribosome appeared later in evolution, is highly unlikely
and unsupported by our data. Such a scenario would
imply that independent of its binding to the ribosome,
EF-P had an alternative unknown function that would
have allowed for its retention during evolution.
Additionally, the alternative hypothesis implies that all
species except the proteobacteria lost poxA or that there
was widespread lateral transfer of efp to all domains
of life. Therefore, we favor the hypothesis that EF-P ori-
ginally interacted with the ribosome, as it is the most
parsimonious.
The modification of EF-P by PoxA is analogous to the
modification of IF5a (the homolog of EF-P) with a
hydroxylated polyamine by two enzymes, deoxyhypusine
synthase and deoxyhypusine hydroxylase (36,37). The
presence of two alternative pathways that produce a
similar outcome highlights the relevance of EF-P modifi-
cation, but at the same time raises the question of how
EF-P functions in organisms that lack PoxA or
deoxyhypusine synthase. In some cases, the lack of
PoxA may be indicative of a lack of EF-P modification,
which, in turn, may result from alternative mechanisms of
ribosome binding or optimization of polyproline transla-
tion. In other instances, organisms may have instead
evolved an alternative pathway for modifying EF-P to
enhance binding to the ribosome, similar to the previously
mentioned IF5a modification in archaea and eukaryotes.
Our data suggest that tRNA mimicry originally allowed
EF-P to bind the ribosome, thereby increasing the fitness
of certain organisms by facilitating synthesis of polypro-
line containing proteins. PoxA evolution from LysRS
likely occurred as a secondary process facilitated by the
fact that EF-P already had several key features similar to
that of a tRNA. The emergence of the PoxA modification
pathway would then have provided additional advantages,
as modified EF-P is far more efficient in stimulating trans-
lation of polyproline stretches than the unmodified form
(10). It is critical that PoxA concurrently lost the ability to
recognize the canonical substrates of LysRS to prevent
synthesis of (R)-b-Lys-tRNA, which would not be a sub-
strate for translation (38,39). Taken together, these and
previous data illustrate the precise mechanism by which
molecular mimicry can be used to enhance protein synthe-
sis, and thus, the fitness of the cell.
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